stockrowAtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.
- Revenue
- +15.0%
- EPS
- +1,583.9%
- Free cash flow
- −0.73%
- Total debt
- −17.3%
Quarter to September 2026, against a year earlier
Follow ATRC
Alert me
AtriCure, Inc. (ATRC) EBITDA
AtriCure, Inc.'s EBITDA for fiscal 2025 was $11.6M, compared with −$20.7M in fiscal 2024. Over the twelve months to 30 June 2026 it was $34.2M. Over the past ten years it has ranged from −$32.9M (fiscal 2020) to $151.2M (fiscal 2021); the current reading is higher than 91% of that period. AtriCure, Inc. ranks 24th of 47 Medical Instruments & Supplies companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $11.6M | — |
| FY2024 | −$20.7M | — |
| FY2023 | −$10.8M | — |
| FY2022 | −$29.0M | — |
| FY2021 | $151.2M | — |
| FY2020 | −$32.9M | — |
| FY2019 | −$24.3M | — |
| FY2018 | −$8.2M | — |
| FY2017 | −$15.6M | — |
| FY2016 | −$21.5M | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $15.1M | 155.37% |
| Mar 2026 | $5.9M | (23.49%) |
| Dec 2025 | $7.7M | 40.39% |
| Sep 2025 | $5.5M | — |
| 42 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| NVST Envista Holdings Corporation compare | $428.9M |
| XRAY DENTSPLY SIRONA Inc. compare | $408.0M |
| MMSI Merit Medical Systems, Inc. compare | $359.6M |
| STVN Stevanato Group S.p.A. compare | $351.1M |
| ICUI ICU Medical, Inc. compare | $314.2M |
| WRBY Warby Parker Inc. compare | $59.0M |
| ATRC AtriCure, Inc. | $34.2M |
| MMED MiniMed Group, Inc. compare | −$8.0M |
| PLSE Pulse Biosciences, Inc compare | −$82.0M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on ATRC
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement